Who owns G1 Therapeutics?
- Ticker: GTHX
- CUSIP Number: 3621lq109
Tip: Access positions for across all investors
Analyze quarterly positions in G1 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of G1 Therapeutics stock
Who bought or sold G1 Therapeutics this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 2.0M | $6.0M | 2% | Dec 2023 |
|
BlackRock | 1.1M | $1.6M | -6% | Sep 2023 |
|
Raymond James & Associates | 566k | $1.7M | -39% | Dec 2023 |
|
D. E. Shaw & Co | 496k | $1.5M | -2% | Dec 2023 |
|
Renaissance Technologies | 474k | $683k | -17% | Sep 2023 |
|
Geode Capital Management | 441k | $635k | 2% | Sep 2023 |
|
Standard Life Aberdeen | 424k | $1.3M | 100% | Dec 2023 |
|
Marshall Wace | 360k | $1.1M | -30% | Dec 2023 |
|
Schonfeld Strategic Advisors | 341k | $1.0M | 100% | Dec 2023 |
|
Jacobs Levy Equity Management | 313k | $955k | -45% | Dec 2023 |
|
Susquehanna International | 300k | $431k | -7% | Sep 2023 |
|
XTX Topco | 297k | $427k | 170% | Sep 2023 |
|
Bank of America Corporation | 280k | $852k | -3% | Dec 2023 |
|
Needham Investment Management | 234k | $337k | 0% | Sep 2023 |
|
Simplex Trading | 234k | $712k | 1237% | Dec 2023 |
|
Jane Street | 223k | $679k | 2041% | Dec 2023 |
|
Connor, Clark & Lunn Investment Management | 192k | $586k | -6% | Dec 2023 |
|
Level Four Advisory Services | 179k | $545k | -3% | Dec 2023 |
|
Two Sigma Investments | 162k | $494k | 79% | Dec 2023 |
|
State Street Corporation | 161k | $232k | 0% | Sep 2023 |
|
Man Group | 147k | $447k | 100% | Dec 2023 |
|
Bridgeway Capital Management | 140k | $202k | 22% | Sep 2023 |
|
Citadel Advisors | 134k | $408k | -38% | Dec 2023 |
|
Two Sigma Advisers | 133k | $405k | -39% | Dec 2023 |
|
Acadian Asset Management | 132k | $189k | 100% | Sep 2023 |
|
Denali Advisors | 122k | $372k | -18% | Dec 2023 |
|
Birchview Capital | 120k | $173k | 200% | Sep 2023 |
|
Northern Trust | 99k | $143k | 0% | Sep 2023 |
|
Citigroup | 86k | $262k | 13267% | Dec 2023 |
|
Franklin Street Advisors | 83k | $254k | 0% | Dec 2023 |
|
Dimensional Fund Advisors | 77k | $234k | 3% | Dec 2023 |
|
Curi Wealth Management | 71k | $216k | 0% | Dec 2023 |
|
683 Capital Management | 64k | $195k | 100% | Dec 2023 |
|
Group One Trading | 47k | $67k | 4275% | Sep 2023 |
|
Virtu Financial | 45k | $136k | 100% | Dec 2023 |
|
Beacon Pointe Advisors | 44k | $133k | 2% | Dec 2023 |
|
Algert Coldiron Investors | 39k | $117k | -44% | Dec 2023 |
|
Ameriprise Financial | 38k | $55k | -70% | Sep 2023 |
|
Creative Financial Designs | 35k | $108k | 98% | Dec 2023 |
|
Rsm Us Wealth Management | 35k | $108k | 100% | Dec 2023 |
|
Morgan Stanley | 35k | $50k | -76% | Sep 2023 |
|
Jump Financial | 34k | $105k | 100% | Dec 2023 |
|
Raymond James Financial Services Advisors | 34k | $103k | -22% | Dec 2023 |
|
Millennium Management | 31k | $95k | -97% | Dec 2023 |
|
GSA Capital Partners | 26k | $79k | 34% | Dec 2023 |
|
Capstone Investment Advisors | 25k | $76k | 100% | Dec 2023 |
|
Envestnet Asset Management | 24k | $35k | 23% | Sep 2023 |
|
Wells Fargo & Company | 23k | $69k | 6% | Dec 2023 |
|
Advisor Group Holdings | 22k | $67k | 16% | Dec 2023 |
|
Charles Schwab Investment Management | 22k | $66k | 0% | Dec 2023 |
|
Cubist Systematic Strategies | 21k | $65k | 0% | Dec 2023 |
|
Prudential Financial | 21k | $30k | 30% | Sep 2023 |
|
Invesco | 21k | $30k | 49% | Sep 2023 |
|
T. Rowe Price Associates | 18k | $55k | 0% | Dec 2023 |
|
Bank of New York Mellon | 18k | $54k | 0% | Dec 2023 |
|
Squarepoint Ops | 16k | $50k | 27% | Dec 2023 |
|
Engineers Gate Manager | 14k | $21k | 100% | Sep 2023 |
|
Two Sigma Securities | 14k | $43k | 100% | Dec 2023 |
|
Financial Advocates Investment Management | 13k | $40k | 100% | Dec 2023 |
|
Cambridge Investment Research Advisors | 12k | $36k | 100% | Dec 2023 |
|
Goldman Sachs Group | 12k | $35k | -30% | Dec 2023 |
|
FMR | 10k | $15k | -44% | Sep 2023 |
|
Tower Research Capital | 8.1k | $12k | -77% | Sep 2023 |
|
Quantbot Technologies | 6.8k | $9.8k | -55% | Sep 2023 |
|
Barclays | 6.3k | $19k | 0% | Dec 2023 |
|
Ables, Iannone, Moore & Associates | 4.7k | $14k | 100% | Dec 2023 |
|
UBS Group | 3.2k | $9.7k | 1393% | Dec 2023 |
|
CWM | 1.5k | $5.0k | 0% | Dec 2023 |
|
Federated Investors | 1.4k | $4.3k | -57% | Dec 2023 |
|
Northwestern Mutual Wealth Management Company | 1.0k | $1.4k | 100% | Sep 2023 |
|
Rhumbline Advisers | 967.00 | $2.9k | 0% | Dec 2023 |
|
Signature | 910.00 | $2.8k | -98% | Dec 2023 |
|
Hanson McClain Advisors | 750.00 | $2.3k | 0% | Dec 2023 |
|
Proequities | 517.00 | $1.6M | 0% | Dec 2023 |
|
Advisory Services Network | 500.00 | $1.5k | 100% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 308.00 | $938.999600 | -51% | Dec 2023 |
|
Jpmorgan Chase & Co | 250.00 | $763.000000 | -97% | Dec 2023 |
|
Providence Capital Advisors | 212.00 | $305.004400 | 0% | Sep 2023 |
|
Goss Wealth Management | 200.00 | $288.000000 | 0% | Sep 2023 |
|
Royal Bank of Canada | 90.00 | $0 | 0% | Dec 2023 |
|
FinTrust Capital Advisors | 65.00 | $94.003000 | 0% | Sep 2023 |
|
ICA Group Wealth Management | 50.00 | $153.000000 | 100% | Dec 2023 |
|
Who sold out of G1 Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Woodline Partners | Jun 2023 | 150k | $375k |
SG Americas Securities | Sep 2023 | 38k | $54k |
Y-Intercept | Jun 2023 | 23k | $57k |
Financial Engines Advisors L.L.C | Jun 2023 | 15k | $38k |
Belvedere Trading | Jun 2023 | 10k | $25k |
Tortoise Investment Management | Sep 2023 | 3.0k | $4.3k |
China Universal Asset Management | Sep 2023 | 1.3k | $2.0k |
Daiwa Securities Group | Sep 2023 | 145.00 | $0 |
Parallel Advisors | Sep 2023 | 50.00 | $72.000000 |